Detalles de la búsqueda
1.
Real-world safety and effectiveness of canakinumab in patients with tumour necrosis factor receptor-associated periodic syndrome or hyperimmunoglobulinaemia D syndrome: Interim results from post-marketing surveillance in Japan.
Mod Rheumatol
; 33(2): 381-391, 2023 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35575279
2.
Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study.
Mult Scler
; 28(8): 1229-1238, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34787005
3.
Dose-dependent reduction in body weight with LIK066 (licogliflozin) treatment in Japanese patients with obesity.
Diabetes Obes Metab
; 22(7): 1102-1110, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32072763
4.
Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study.
BMC Neurol
; 17(1): 17, 2017 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28129749
5.
Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension.
BMC Neurol
; 14: 21, 2014 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-24475777
6.
Safety and efficacy of vildagliptin: 52-week post-marketing surveillance of Japanese patients with type 2 diabetes in combination with other oral antidiabetics and insulin.
Expert Opin Pharmacother
; 21(1): 121-130, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31689132
7.
Relationship of patient background with macro- and microvascular complications: a 2-year post-marketing surveillance of vildagliptin in nearly 20,000 Japanese diabetic patients.
Expert Opin Pharmacother
; 20(8): 1037-1047, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30831038
8.
Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study.
Diabetes Ther
; 6(4): 559-571, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26620049
Resultados
1 -
8
de 8
1
Próxima >
>>